(1994) Determinants of survival in idiopathic pulmoꠀnary fibrosis,

(2000) [Idiopathic diffuse interstitial lung disease],

(amrevrespirdis1991) prine combined with prednisone in the treatment of idiopathic pulmonary fibrosis,

(1998) Colꠀchicine, D-penicillamine, and prednisone in the treatment of idiopathic pulmonary fibroꠀ;sis: a controlled clinical trial,

(2001) Type 1/type 2 cytoꠀkine paradigm and the progression of pulmonary fibrosis,

(2000) TIMP-1, -2, -3, and -4 in idiopathic pulmoꠀ;nary fibrosis,

(1999) A preliminary study of long-term treatment with interferon gamma- 1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis,

(1961) The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid,

(amrevrespirdis1978) Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin,

(2002) Time course of bleomycin- induced lung fibrosis,

(jimmunol1984) pressive activity by inhibiting prostaglandin E2 release and inducing interleukin 1 proꠀ,

(1985) Interleukin 1:an immunological perspective,

(2001) Matrix metalloproꠀteinases in lung biology,

(1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling,

(1995) Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease,

(1999) Diverse roles of macrophage matrix metalloproteinases in tissue destruꠀction and tumor growth,

(1986) Tumor necrosis factor production by human sarcoid alveolar macrophages,

(1991) The role of TGF-beta in pulmonary fibrosis,

(jimmunol1989) Monokine production by hypersensitivity Evidence for sequeꠀ ntial production of IL-1 and tumor necrosis factor,

(1988) Effect of murine gamma interferon on the cellular responses to bleoꠀmycin in mice,

(1999) Selective inhibition of collagen gene expresꠀsion in fibroblasts by an interferon-gamma transgene,

(1999) Overexpression of alveolar macrophage gelatinase B(MMP-9) in patients with idiopathic pulmonary fibrosis: effects of steroid and immunosuppressive treatment,

(2000) Characteristic elevation of matrix metalloꠀproteinase activity in idiopathic interstitial pneumonias,

(1993) Cellular activation of the 72 kDa type IV procollagenase/TIMP-2 complex,

(2000) SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung,

(2001) Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat,

(2000) Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin,

(2003) Matrix metalloproꠀteinase-9 in lung remodeling,

(1998) In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1,

Tissue inhibitor of metalloproteinases lates the secretion of collagenase from human skin fibroblasts,

(2001) Selective induction of tissue inhibitor of metalloproteinase-1 in bleomycin-induced pulꠀmonary fibrosis,

(1999) Matrix metalloproteinases 2, 9, and 13, and tissue inhibitors of metalloproteinases 1 and 2 in experimental lung silicosis,

(2001) Attenuation of lung inflammation and fibrosis in interferon-gamma-deficient mice after intratracheal bleomycin,

(1993) PCR analysis of cytokine induction profiles associated with mouse strain variation in susceptibility to pulmonary fibrosis,

(2003) Dual roles of IL-4 in lung injury and fibrosis,